ARUBA: "Medical Management With or Without Interventional Therapy for Unruptured Brain Arteriovenous Malformations"
The clinical benefit of preventive eradication of unruptured brain arteriovenous malformations remains uncertain.
A randomised trial of unruptured Brain Arteriovenous malformations (ARUBA) aims to compare the risk of death and symptomatic stroke in patients with an unruptured brain arteriovenous malformation who are allocated to either medical management alone or medical management with interventional therapy.
Read More
The Mount Sinai Hospital Ranked Among World’s Best in Newsweek/Statista Rankings
Mar 10, 2026 View All Press Releases
Mount Sinai Health System to Roll Out Microsoft Dragon Copilot
Nov 05, 2025 View All Press Releases
NIH Awards $10 Million for the New York Regional Diabetes Research Center
Oct 23, 2025 View All Press Releases